Massachusetts Financial Services’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$622K Buy
138,146
+20,710
+18% +$108K ﹤0.01% 880
2025
Q4
$722K Buy
+117,436
New +$852K ﹤0.01% 850
2016
Q4
Sell
-21,524
Closed -$443K 883
2016
Q3
$443K Buy
21,524
+4,824
+29% +$122K ﹤0.01% 815
2016
Q2
$511K Sell
16,700
-1,024
-6% -$35.6K ﹤0.01% 788
2016
Q1
$663K Sell
17,724
-488
-3% -$18.4K ﹤0.01% 754
2015
Q4
$786K Buy
+18,212
New +$769K ﹤0.01% 747
2013
Q4
Sell
-26,210
Closed -$616K 848
2013
Q3
$616K Sell
26,210
-960
-4% -$27.3K ﹤0.01% 775
2013
Q2
$730K Buy
+27,170
New +$787K ﹤0.01% 750

Other funds holding MYGN